FDA · FIDIA - S.P.A. · Financials
Market Cap
14.24M EUR
Shares
1.25B
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Browse captured authority reports and their original financial labels
Revenue
19.06M
-36.3%
FY2024
Net Income
-9.3M
-611.4%
FY2024
Operating Margin
-34.48%
-29pp
FY2024
Operating Cash Flow
-4.84M
-710%
FY2023
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| EUR | 19.06M | 29.94M | 25.85M | 25.28M |
| EUR | 1.64M | 1.43M | 2.3M | 2M |
| EUR | -6.57M | -1.65M | -4.92M | -1.58M |
| EUR | -9.18M | -1.23M | 5.55M | -3.26M |
| EUR | 313K | 248K | -206K | 238K |
| EUR | -9.3M | -1.31M | 5.97M | -3.2M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Short-term borrowings | 2024-12-31 | EUR 480,000 | ESEF Annual Report filed 2025-04-30 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.